Evidence map›Paper›PMID 9609110›Full record

ReviewMolecular and cellular biochemistry1998

Role of binding proteins to IRS-1 in insulin signalling.

W Ogawa, T Matozaki, M Kasuga

Abstract readReview
PubMed
In one paragraph

Review in Molecular and cellular biochemistry, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Klotho and the aging process.The Korean journal of internal medicine · 2011
    Review
  12. Frontier of epilepsy research - mTOR signaling pathway.Experimental & molecular medicine · 2011
    Review
  13. Oxidative stress, insulin signaling, and diabetes.Free radical biology & medicine · 2011
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

W OgawaSecond Department of Internal Medicine, Kobe University School of Medicine, Japan.
T Matozaki
M Kasuga

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin elicits its divergent metabolic and mitogenic effects by binding to its specific receptor, which belongs to the family of receptor tyrosine kinases. The activated insulin receptor phosphorylates the intracellular substrate IRS-1, which then binds various signalling molecules that contain SRC homology 2 domains, thereby propagating the insulin signal. Among these IRS-1-binding proteins, the Grb2-Sos complex and the protein tyrosine phosphatase SHP-2 transmit mitogenic signals through the activation of Ras, and phosphoinositide 3-kinase is implicated in the major metabolic actions of insulin. Although substantial evidence indicates the importance of IRS-1 in insulin signal transduction, the generation of IRS-1-deficient mice has revealed the existence of redundant signalling pathways.

Indexed as

AnimalsCarrier ProteinsHumansInsulinInsulin Receptor Substrate ProteinsPhosphoproteinsReceptor, InsulinSignal TransductionStructure-Activity RelationshipCarrier ProteinsInsulinInsulin Receptor Substrate ProteinsIRS1 protein, humanIrs1 protein, mousePhosphoproteinsReceptor, Insulin

Identifiers

PMID9609110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.